Hotspur Technologies

Attachments

*Architects: Diabetes, Dialysis, Renal & Kidney Disease Companies (Health IT, Devices & Technology)
*Architects: Surgical & Diagnostic Technology _ Vascular, PAD (Peripheral Arterial Disease & CLI (Critical Limb Ischemia)
*Portfolio Companies: Finistere Partners
Companies: Acquired_(M&A)
Finance & Acquisitions: Teleflex
Incept LLC
Industry: Silicon Valley, California

Founded 2008
Hotspur has managed to make it this far on just $5 million raised over two rounds (2010)
Hotspur Proves It’s Possible to Do a Very Low- Cost Medical Device Company (2010)
Hotspur's products are based on unique and groundbreaking technology that opens blood vessels more efficiently and less invasively.
Hotspur's unique technology known as the VisioValve™ injection system is the foundation of its initial products.
Its backers are Onset, Bio-Star Private Equity Fund, Finistere Partners, Saratoga Ventures, Three Arch Partners and Versant Ventures
Leading developer of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels.
Mountain View, California
Spun out of Incept, LLC, the company's first three products are focused on the dialysis and vascular access space.
Teleflex Incorporated Acquires Hotspur for $15m (2012)
The IQCath™ Balloon Dilatation Catheter, GPSCath™ Balloon Dilatation Catheter, and the Keeper™ Embolectomy Catheter received 510(k) clearance from the FDA in July 2010 and became commercially available in the U.S. in December 2010.